Skip to main content
Premium Trial:

Request an Annual Quote

Political Science

Scientists in the UK got political this week, staging a mock funeral for science at 10 Downing Street to protest what they see as unfair funding regulations. The march was organized by a new science lobbying group called Science for the Future. But too few researchers are willing to engage in politics, even though they should, says The Guardian's Adam Smith. Jon Spiers, former policy and campaign manager at Cancer Research UK, tells Smith that "the average scientist doesn't appreciate how policy is made or, therefore, how they can influence it."

So, Smith says, researchers need to get political if they want to make sure that their interests are taken into consideration when policy is made. Some researchers stay quiet because they're worried their funding will be in jeopardy if they protest, while others are too busy with publishing papers or getting grants to have time to participate in the political process, Smith says. But, he adds, "Like it or not, scientists, sometimes you have to swap the pipette for the placard."

The Scan

Study Finds Few FDA Post-Market Regulatory Actions Backed by Research, Public Assessments

A Yale University-led team examines in The BMJ safety signals from the US FDA Adverse Event Reporting System and whether they led to regulatory action.

Duke University Team Develops Programmable RNA Tool for Cell Editing

Researchers have developed an RNA-based editing tool that can target specific cells, as they describe in Nature.

Novel Gene Editing Approach for Treating Cystic Fibrosis

Researchers in Science Advances report on their development of a non-nuclease-based gene editing approach they hope to apply to treat cystic fibrosis.

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.